ALEMBICLTDNSEAlembic Limited· PharmaceuticalsHighNeutral
Announced Mon, 10 Nov · 16:59 IST

Alembic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alembic Limited has filed its unaudited/reviewed financial results for the quarter and half-year ended September 30, 2025 with NSE. The headline announcement confirms only that results have been submitted — the actual revenue, profit, margin, balance sheet figures and auditor observations are not provided in the filing snippet. No comparative figures, growth rates, or auditor qualifications are visible from the text supplied. To assess performance or signal triggers, the full results PDF (including the auditor's review report and segment data) would need to be reviewed.

Likely market impact

This is a routine regulatory filing confirming compliance with listing obligations; on its own it carries no directional signal for the stock price. Investors should look at the detailed results (revenue, PAT, margins, debt levels and any auditor remarks) to judge the company's actual performance for the quarter.